AVENUE THERAPEUTICS, INC. (ATXI) Operating cash flow 2016–2025
AVENUE THERAPEUTICS, INC. (ATXI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.8MFY2025 · since FY2016: -$1.6M → -$1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.8M | +79.7% |
| FY2024 | -$9.0M | +4.5% |
| FY2023 | -$9.5M | -24.4% |
| FY2022 | -$7.6M | -102.6% |
| FY2021 | -$3.8M | +18.7% |
| FY2020 | -$4.6M | +82.4% |
| FY2019 | -$26.3M | -44.2% |
| FY2018 | -$18.2M | -167.8% |
| FY2017 | -$6.8M | -316.8% |
| FY2016 | -$1.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice